2025-04252Notice

Behind Closed Doors: Funding New Medical Product Ideas

Published Date: 3/17/2025

Notice

Summary

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 14, 2025, to review secret grant applications for new product development. This meeting affects researchers seeking funding and keeps sensitive info private. No public access means the focus is on protecting ideas and personal details while deciding who gets money.

Free Policy Watch

New rules are filed every week. Most people never see them.

Pick a topic. PRIA watches every federal rule and tells you when one hits your household.

Pick a topic to get started

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Closed NIH Review Protects Applicants' Secrets

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 14, 2025 (10:00 a.m. to 1:30 p.m.) to review and evaluate grant applications for the R34 Planning for Product Development Strategy. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets or patentable material and personal information of individuals associated with the applications.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
3/17/2025
4/14/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
National Institutes of Health
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in